Log in

Sorrento Therapeutics SEC Filings & 10K Form (NASDAQ:SRNE)

$1.73
+0.12 (+7.45 %)
(As of 10/17/2019 08:00 AM ET)
Today's Range
$1.65
Now: $1.73
$1.78
50-Day Range
$1.50
MA: $2.11
$2.51
52-Week Range
$1.39
Now: $1.73
$6.50
Volume2.48 million shs
Average Volume2.22 million shs
Market Capitalization$230.97 million
P/E RatioN/A
Dividend YieldN/A
Beta2.4

SEC Filings

Sorrento Therapeutics (NASDAQ:SRNE) SEC Filings

DateFilerForm TypeView
10/09/2019
10:46 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:18 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:15 PM
Sorrento Therapeutics (Filer)
Form 424B5
10/01/2019
3:32 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
3:28 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
3:26 PM
Sorrento Therapeutics (Filer)
Form 424B5
10/01/2019
1:23 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
09/25/2019
4:31 PM
OAKTREE CAPITAL MANAGEMENT LP (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
09/23/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
5:06 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
4:19 PM
Sorrento Therapeutics (Filer)
Form DEF 14A
08/14/2019
12:39 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
08/12/2019
9:10 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
9:07 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:49 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
3:49 PM
Sorrento Therapeutics (Filer)
Form PRE 14A
07/02/2019
11:52 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
07/01/2019
3:53 PM
Sorrento Therapeutics (Filer)
Form 424B3
06/28/2019
4:20 PM
Sorrento Therapeutics (Filer)
Form 424B5
06/28/2019
4:17 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
5:06 AM
Sorrento Therapeutics (Subject)
Form FWP
06/28/2019
5:06 AM
Sorrento Therapeutics (Filer)
Form 424B5
06/20/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:40 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:28 PM
Sorrento Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/17/2019
8:22 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
3:46 PM
Sorrento Therapeutics (Filer)
Form CT ORDER
06/05/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
4:07 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
4:00 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2019
9:41 AM
Sorrento Therapeutics (Filer)
Form CT ORDER
05/13/2019
3:02 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
3:01 PM
Sorrento Therapeutics (Filer)
Form NT 10-Q
05/09/2019
4:14 PM
Opko Health, Inc. (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13D
05/07/2019
11:15 PM
Sorrento Therapeutics (Filer)
Form EFFECT
05/07/2019
3:54 PM
Sorrento Therapeutics (Filer)
Form 424B3
05/03/2019
4:01 PM
Sorrento Therapeutics (Filer)
Form S-3/A
05/03/2019
3:01 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
8:17 PM
Sorrento Therapeutics (Filer)
Form 10-K/A
04/23/2019
8:03 PM
SHAH JAISIM (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
8:02 PM
Lemus David (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
8:02 PM
Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
8:01 PM
Ji Henry (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
8:00 PM
Followwill Dorman (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
8:00 PM
Sorrento Therapeutics (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
7:59 PM
Shao Jiong (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2019
8:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2019
5:08 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2019
12:14 PM
Sorrento Therapeutics (Filer)
Form 8-K/A
04/03/2019
8:01 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
5:46 AM
Sorrento Therapeutics (Filer)
Form 424B5
03/15/2019
5:30 AM
Sorrento Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2019
4:16 PM
Sorrento Therapeutics (Filer)
Form NT 10-K
02/13/2019
5:05 AM
Ally Bridge Group Capital Partners II, L.P. (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
02/11/2019
4:28 PM
Sorrento Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/23/2019
8:35 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2019
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2018
11:18 PM
Sorrento Therapeutics (Filer)
Form EFFECT
12/21/2018
3:51 PM
Sorrento Therapeutics (Filer)
Form 424B3
12/13/2018
5:12 AM
Asia Pacific MedTech Ltd (0001704813) (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
12/13/2018
5:10 AM
China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
12/13/2018
5:08 AM
Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
12/12/2018
8:30 PM
Sorrento Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/27/2018
6:49 PM
Sorrento Therapeutics (Issuer)
ZELDIS JEROME B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:49 PM
Shao Jiong (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:48 PM
Sorrento Therapeutics (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:48 PM
SHAH JAISIM (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:47 PM
Lemus David (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:47 PM
Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
6:46 PM
Followwill Dorman (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:04 PM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
4:07 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
6:00 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
3:12 PM
ABG II-SO Ltd (Reporting)
ABG Innovation-SO Ltd (Reporting)
ABG Management Ltd (Reporting)
ABG SRNE Ltd (Reporting)
Ally Bridge Group Capital Partners II, L.P. (Reporting)
Ally Bridge Group Innovation Capital Partners III, L.P. (Reporting)
Ally Bridge LB Healthcare Master Fund Ltd (Reporting)
Ally Bridge LB Management Ltd (Reporting)
Li Bin (Reporting)
Sorrento Therapeutics (Issuer)
Yu Fan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
3:41 PM
Sorrento Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/10/2018
5:03 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2018
5:03 AM
Sorrento Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
4:21 PM
Sorrento Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
3:14 PM
Sorrento Therapeutics (Filer)
Form DEFA14A
07/23/2018
5:50 AM
Ji Henry (Reporting)
Sorrento Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
3:18 PM
Sorrento Therapeutics (Filer)
Form DEFA14A
07/19/2018
3:04 PM
Sorrento Therapeutics (Filer)
Form DEF 14A
07/13/2018
5:05 AM
Magnum Opus 2 International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
07/13/2018
5:02 AM
Magnum Opus 2 International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
07/09/2018
4:19 PM
Sorrento Therapeutics (Filer)
Form PRER14A
06/27/2018
4:04 PM
Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
06/27/2018
4:01 PM
Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
06/27/2018
4:00 PM
Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
06/22/2018
3:29 PM
Asia Pacific MedTech Ltd (0001704813) (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
06/22/2018
3:28 PM
China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G/A
06/22/2018
3:27 PM
Sorrento Therapeutics (Subject)
Top Path Asia Ltd (Filed by)
Form SC 13G
06/22/2018
3:27 PM
Hongguo International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
06/22/2018
3:26 PM
China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
06/22/2018
3:23 PM
Sorrento Therapeutics (Subject)
Top Path Asia Ltd (Filed by)
Form SC 13G
06/22/2018
3:18 PM
Hongguo International Holdings Ltd (Filed by)
Sorrento Therapeutics (Subject)
Form SC 13G
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel